DNDI-6148 is a research compound that inhibits the Leishmania CPSF3 endonuclease, demonstrating activity against cutaneous leishmaniasis in experimental models. It serves as a valuable tool for studying visceral leishmaniasis pathogenesis and for anti-parasitic drug discovery in both in vitro and in vivo settings.
Molekulargewicht:
335.13
Reinheit:
99.55% (May vary between batches)
CAS Nummer:
[2243909-59-1]
Formel:
C16H14BN5O3
Target-Kategorie:
Parasite
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten